Serum galactomannan testing after bronchoalveolar lavage in the ICU. Is it complementary and necessary or redundant?

Conflict of interest statement

The authors declare no conflict of interest.

Author contributions

The authors have contributed to the writing and review of the topic.

Funding

None.

Ethical approval of studies and informed consent

Not applicable.

Acknowledgments

None.

References

[1] Gaffney S, Kelly DM, Rameli PM, Kelleher E, Martin-Loeches I. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices. APMIS. 2023; 131(11):654-667. doi:10.1111/apm.13316

[2] Maertens J, Maertens V, Theunissen K, et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis. 2009; 49(11):1688-1693. doi:10.1086/647935

[3] Wehbe S, Chaftari AM, Hachem R, et al. Prognostic value of serum and bronchoalveolar lavage fluid galactomannan levels in invasive aspergillosis: an 8-year experience at a tertiary cancer center. J Fungi (Basel). 2025; 11(5):355. doi:10.3390/jof11050355

[4] Zhou W, Li H, Zhang Y, et al. Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary aspergillosis. J Clin Microbiol. 2017; 55(7):2153-2161. doi:10.1128/JCM.00345-17

[5] Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2024. doi:10.1093/cid/ciae104

[6] Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med. 2008; 177(1):27-34. doi:10.1164/rccm.200704-606OC

[7] Heng SC, Morrissey O, Chen SC, et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis. Crit Rev Microbiol. 2015; 41(1):124-134. doi:10.3109/1040841X.2013.804033

[8] Dai Z, Cai M, Yao Y, et al. Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis. Medicine (Baltimore). 2021; 100(14):e25233. doi:10.1097/MD.0000000000025233

[9] Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016; 63(4):e1-e60. doi:10.1093/cid/ciw326

[10] Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019; 200(5):535-550. doi:10.1164/rccm.201906-1185ST

[11] Huang L, Zhang Y, Hua L, Zhan Q. Diagnostic value of galactomannan test in non-immunocompromised critically ill patients with influenza-associated aspergillosis: data from three consecutive influenza seasons. Eur J Clin Microbiol Infect Dis. 2021; 40(9):1899-1907. doi:10.1007/s10096-021-04228-z

[12] Liu L, Li J, Dong H, et al. Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019; 31(3):331-335. doi:10.3760/cma.j.issn.2095-4352.2019.03.014